Table 4.

The incidence of adverse reactions with PNS for CAD.

Adverse events	The incidence of adverse reactions (experimental)	The incidence of adverse reactions (control)	References
Elevated transaminase	0/36	2/35	Feng et al., 2016
Gastrointestinal discomfort	0/36	1/35	Feng et al., 2016
Muscle pain	0/36	1/35	Feng et al., 2016
Subcutaneous hemorrhage	1/28	0/27	Yan et al., 2015
Fecal occult blood positive	1/28	1/27	Yan et al., 2015
Nausea	0/28	1/27	Yan et al., 2015
Rash	1/50	0/50	Yu, 2010
Total	3/214	6/208